Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 3 (2007), Issue 4 (April)

1. Involvement of dendritic cell frequency and function in virological relapse in pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C patients.
   J Med Virol, 79(5): 511-21. [Abstract] [Full-text]
2. Treatment of chronic he1patitis C genotype 1 with peginterferon-alpha2a (40 kDa) plus ribavirin under routine clinical practice in Spain: early prediction of sustained virological response rate.
   Aliment Pharmacol Ther, 25(8): 899-906. [Abstract] [Full-text]
3. Early virological suppression is associated with good maintained response to adefovir dipivoxil in lamivudine resistant chronic hepatitis B.
   Aliment Pharmacol Ther, 25(8): 891-8. [Abstract] [Full-text]
4. Adherence to antiretroviral therapy and virologic suppression among HIV-infected persons receiving care in private clinics in Mumbai, India.
   Clin Infect Dis, 44(9): 1235-44. [Abstract] [Full-text]
5. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART.
   AIDS, 21(7): 835-43. [Abstract] [Full-text]
6. Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
   AIDS, 21(6): 721-32. [Abstract] [Full-text]
7. Intensification of a triple-nucleoside regimen with tenofovir or efavirenz in HIV-1-infected patients with virological suppression.
   AIDS, 21(7): 813-23. [Abstract] [Full-text]
8. Efficacy and safety of adefovir dipivoxil 20 mg daily in HBeAg-positive patients with lamivudine-resistant hepatitis B virus and a suboptimal virological response to adefovir dipivoxil 10 mg daily.
   J Hepatol, 46(5): 791-6. [Abstract] [Full-text]
9. Immunologic, virologic, and neuropsychologic responses in human immunodeficiency virus-infected children receiving their first highly active antiretroviral therapy regimen.
   Viral Immunol, 20(1): 131-41. [Abstract] [Full-text]
10. Sustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from Taiwan.
    Aliment Pharmacol Ther, 25(9): 1029-37. [Abstract] [Full-text]
11. Assay of HIV gp41 amino acid sequence to identify baseline variation and mutation development in patients with virologic failure on enfuvirtide.
    Antiviral Res, 75(1): 58-63. [Abstract] [Full-text]
12. A virologic pilot study of valacyclovir in infectious mononucleosis.
    J Clin Virol, 39(1): 16-21. [Abstract] [Full-text]
13. Lamivudine/abacavir maintains virological superiority over zidovudine/lamivudine and zidovudine/abacavir beyond 5 years in children.
    AIDS, 21(8): 947-55. [Abstract] [Full-text]
14. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%.
    J Acquir Immune Defic Syndr, 45(1): 4-8. [Abstract] [Full-text]
15. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    HIV Med, 8(4): 213-9. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.